Clinical Trial Update: Lantus Versus Humalog Mix as add-on Therapy in Type Diabetes Patients Failing Sulfonylurea and Metformin Combination Treatment [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating Lantus (insulin glargine) versus Humalog Mix as add-on therapy in adults with type 2 diabetes failing sulfonylurea and metfo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Humalog Mix (insulin lispro mix)
• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED